Concerns arise about studies conducted overseas

12/1/2008 | Wall Street Journal, The

Western drugmakers and regulators are under mounting pressure to ensure the safety of clinical trials conducted in developing countries after reports of death and complications in participants. Some experts are concerned about possible violations of clinical-testing rules, while others worry that companies may be taking advantage of individuals desperate to join studies. Drugmakers said they follow the rules when conducting trials abroad, including securing government authorization and routinely inspecting sites.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC